Royal Bank of Canada’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2K | Buy |
231
+187
| +425% | +$1.82K | ﹤0.01% | 6672 |
|
|
2025
Q4 | $0 | Sell |
44
-18,999
| -100% | -$293K | ﹤0.01% | 7201 |
|
|
2025
Q3 | $463K | Buy |
19,043
+16,019
| +530% | +$267K | ﹤0.01% | 4546 |
|
|
2025
Q2 | $49K | Buy |
3,024
+2,987
| +8,073% | +$51.6K | ﹤0.01% | 5929 |
|
|
2025
Q1 | $1K | Sell |
37
-116
| -76% | -$3.31K | ﹤0.01% | 6636 |
|
|
2024
Q4 | $6K | Sell |
153
-1,251
| -89% | -$47.9K | ﹤0.01% | 6478 |
|
|
2024
Q3 | $45K | Sell |
1,404
-883
| -39% | -$49K | ﹤0.01% | 5747 |
|
|
2024
Q2 | $187K | Buy |
2,287
+1,172
| +105% | +$127K | ﹤0.01% | 4823 |
|
|
2024
Q1 | $162K | Sell |
1,115
-1,216
| -52% | -$103K | ﹤0.01% | 4856 |
|
|
2023
Q4 | $215K | Buy |
2,331
+525
| +29% | +$53.4K | ﹤0.01% | 5051 |
|
|
2023
Q3 | $298K | Buy |
1,806
+1,439
| +392% | +$187K | ﹤0.01% | 4460 |
|
|
2023
Q2 | $23K | Buy |
367
+173
| +89% | +$10.5K | ﹤0.01% | 6135 |
|
|
2023
Q1 | $7K | Sell |
194
-396
| -67% | -$20.7K | ﹤0.01% | 6446 |
|
|
2022
Q4 | $34K | Buy |
590
+520
| +743% | +$32.1K | ﹤0.01% | 6083 |
|
|
2022
Q3 | $6K | Buy |
70
+15
| +27% | +$2.13K | ﹤0.01% | 6646 |
|
|
2022
Q2 | $12K | Sell |
55
-213
| -79% | -$71.3K | ﹤0.01% | 6296 |
|
|
2022
Q1 | $147K | Sell |
268
-58
| -18% | -$35.1K | ﹤0.01% | 5360 |
|
|
2021
Q4 | $215K | Buy |
326
+147
| +82% | +$112K | ﹤0.01% | 5267 |
|
|
2021
Q3 | $150K | Buy |
179
+125
| +231% | +$127K | ﹤0.01% | 5414 |
|
|
2021
Q2 | $68K | Sell |
54
-208
| -79% | -$235K | ﹤0.01% | 5830 |
|
|
2021
Q1 | $288K | Buy |
262
+126
| +93% | +$166K | ﹤0.01% | 4650 |
|
|
2020
Q4 | $193K | Buy |
136
+12
| +10% | +$12.8K | ﹤0.01% | 4882 |
|
|
2020
Q3 | $87K | Sell |
124
-28
| -18% | -$20.4K | ﹤0.01% | 5048 |
|
|
2020
Q2 | $107K | Sell |
152
-322
| -68% | -$186K | ﹤0.01% | 4812 |
|
|
2020
Q1 | $166K | Buy |
474
+110
| +30% | +$77.9K | ﹤0.01% | 4449 |
|
|
2019
Q4 | $228K | Sell |
364
-555
| -60% | -$271K | ﹤0.01% | 4548 |
|
|
2019
Q3 | $308K | Sell |
919
-145
| -14% | -$46.5K | ﹤0.01% | 4158 |
|
|
2019
Q2 | $276K | Buy |
1,064
+665
| +167% | +$133K | ﹤0.01% | 4261 |
|
|
2019
Q1 | $66K | Buy |
399
+199
| +100% | +$32.4K | ﹤0.01% | 5023 |
|
|
2018
Q4 | $22K | Buy |
200
+53
| +36% | +$8.94K | ﹤0.01% | 5539 |
|
|
2018
Q3 | $37K | Buy |
147
+2
| +1% | +$430 | ﹤0.01% | 5373 |
|
|
2018
Q2 | $31K | Buy |
+145
| New | +$26.8K | ﹤0.01% | 5356 |
|
Other funds holding CDLX
CIP
VCM
6CM
KGAMU
WPM
RC
QOP
Royal Bank of Canada's CDLX Position: Q1 2026 in Review
Royal Bank of Canada increased its Cardlytics (CDLX) stake by 425% in Q1 2026, buying an estimated $1.82K and bringing the position to 231 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #6672.
Royal Bank of Canada first reported a position in CDLX in Q2 2018 and has held it in 32 quarters since. The position peaked at $463K in Q3 2025. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.
- Royal Bank of Canada held 231 shares of Cardlytics worth $2K as of Q1 2026.
- Royal Bank of Canada bought 187 Cardlytics shares in Q1 2026, an estimated $1.82K.
- Cardlytics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6672 holding.
- Royal Bank of Canada first reported a position in Cardlytics in Q2 2018 and has held it in 32 quarters since.
- Royal Bank of Canada's Cardlytics position peaked at $463K in Q3 2025.
- 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.